|
Spencer, Brian; Kim, Changyoun; Gonzalez, Tania et al. (2016) ?-Synuclein interferes with the ESCRT-III complex contributing to the pathogenesis of Lewy body disease. Hum Mol Genet 25:1100-15
|
|
Suberbielle, Elsa; Djukic, Biljana; Evans, Mark et al. (2015) DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice. Nat Commun 6:8897
|
|
Rockenstein, Edward; Overk, Cassia R; Ubhi, Kiren et al. (2015) A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies. PLoS One 10:e0121570
|
|
Dewji, Nazneen N; Singer, S Jonathan; Masliah, Eliezer et al. (2015) Peptides of presenilin-1 bind the amyloid precursor protein ectodomain and offer a novel and specific therapeutic approach to reduce ß-amyloid in Alzheimer's disease. PLoS One 10:e0122451
|
|
Games, Dora; Valera, Elvira; Spencer, Brian et al. (2014) Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models. J Neurosci 34:9441-54
|
|
Borlikova, Gilyana G; Trejo, Margarita; Mably, Alexandra J et al. (2013) Alzheimer brain-derived amyloid ýý-protein impairs synaptic remodeling and memory consolidation. Neurobiol Aging 34:1315-27
|
|
Games, Dora; Seubert, Peter; Rockenstein, Edward et al. (2013) Axonopathy in an ?-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated ?-synuclein. Am J Pathol 182:940-53
|
|
Suberbielle, Elsa; Sanchez, Pascal E; Kravitz, Alexxai V et al. (2013) Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-?. Nat Neurosci 16:613-21
|
|
Sekigawa, Akio; Fujita, Masayo; Sekiyama, Kazunari et al. (2012) Distinct mechanisms of axonal globule formation in mice expressing human wild type ýý-synuclein or dementia with Lewy bodies-linked P123H ýý-synuclein. Mol Brain 5:34
|
|
Mandler, Markus; Rockenstein, Edward; Ubhi, Kiren et al. (2012) Detection of peri-synaptic amyloid-? pyroglutamate aggregates in early stages of Alzheimer's disease and in A?PP transgenic mice using a novel monoclonal antibody. J Alzheimers Dis 28:783-94
|
Showing the most recent 10 out of 81 publications
